SCIENTIFIC EVENTS

AFSA – IABS Conference about Animal testing replacement for vaccines: A One Health View: global outlook and future strategy

December 2-4, 2025
Bangkok, Thailand
HYBRID MEETING

Learn more

2nd IABS Real World Evidence Workshop : The Role of
Alternative Approaches to Phase 3 Clinical Trials for
Vaccine Efficacy and Licensure

December 10-11, 2025
Montreal, Canada
HYBRID MEETING

Learn more

Advances in Analytical Technologies for
Biopharmaceutical Products

June, 2026
Virtual Meeting

Learn more

Preterm Birth as a Sentinel Outcome in Maternal Immunization with focus on fetal outcomes – Methods and Context

May/June, 2026
Eastern Europe  

On the Horizon

Bovine Serum: challenges and opportunities in the research and development and manufacture of vaccines and other biological products

September, 2026
Budapest, Hungary

On the Horizon

NEWS

Thank you to everyone who participated in the 11th IABS Statistics Workshop!

From October 20–23, 2025, we had the privilege of bringing together an international community of statisticians, researchers, and professionals around the theme…

Read more

ADVAC

Inno4Vac Ethics Workshop

Today, experts from academia, industry, regulatory agencies, and ethics committees gathered in Leiden, The Netherlands, for a dedicated workshop on the ethical and regulatory landscape…

Learn more

The IABS GHS Workshop 2025 concluded this week in Tokyo

Beyond the technical content, the workshop successfully offered participants a new perspective on how specifications can be designed….

Learn more

IABS COLLABORATIONS

Inno4Vac – Innovations to accelerate vaccine development and manufacture

Inno4Vac is a public-private partnership that addresses scientific bottlenecks in vaccine development.

It proposes to develop predictive biological and mathematical models of vaccine performance and bio-manufacturing.

The IABS European Affiliate (IABS-EU) is part of consortia and has been selected to drive the regulatory part of the project.

ASFaVIP – African swine fever attenuated live
vaccines in pigs

TESTIMONIALS

Paul Henri Lambert

Professor at University of Geneva
Founder of ADVAC

 “I have appreciated the achievements of IABS since many years. It is a unique independent organization that can…

Read more

John Petricciani

Past President
Advisor to the Board

“ Cell substrates have been a key element in the evolution of biological products since the…

Read more

Kathryn Zoon

NIH Scientist Emeritus
Past NIAID Scientific Director

As a long term US regulator and scientist, I have been working with IABS for many years. The IABS has …

Read more

Philippe Duclos

Director ADVAC
University of Geneva

“ A vibrant organization that allows dialogue beyond professional boundaries…

Read more

IABS
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.